View Item 

Show simple item record

A fiveâ CpG DNA methylation score to predict metastaticâ lethal outcomes in men treated with radical prostatectomy for localized prostate cancer
dc.contributor.authorZhao, Shanshan
dc.contributor.authorLeonardson, Amy
dc.contributor.authorGeybels, Milan S.
dc.contributor.authorMcDaniel, Andrew S.
dc.contributor.authorYu, Ming
dc.contributor.authorKolb, Suzanne
dc.contributor.authorZong, Hong
dc.contributor.authorCarter, Kelly
dc.contributor.authorSiddiqui, Javed
dc.contributor.authorCheng, Anqi
dc.contributor.authorWright, Jonathan L.
dc.contributor.authorPritchard, Colin C.
dc.contributor.authorLance, Raymond
dc.contributor.authorTroyer, Dean
dc.contributor.authorFan, Jian‐bing
dc.contributor.authorOstrander, Elaine A.
dc.contributor.authorDai, James Y.
dc.contributor.authorTomlins, Scott A.
dc.contributor.authorFeng, Ziding
dc.contributor.authorStanford, Janet L.
dc.date.accessioned2018-09-04T20:08:21Z
dc.date.available2019-12-02T14:55:10Zen
dc.date.issued2018-10
dc.identifier.citationZhao, Shanshan; Leonardson, Amy; Geybels, Milan S.; McDaniel, Andrew S.; Yu, Ming; Kolb, Suzanne; Zong, Hong; Carter, Kelly; Siddiqui, Javed; Cheng, Anqi; Wright, Jonathan L.; Pritchard, Colin C.; Lance, Raymond; Troyer, Dean; Fan, Jian‐bing ; Ostrander, Elaine A.; Dai, James Y.; Tomlins, Scott A.; Feng, Ziding; Stanford, Janet L. (2018). "A fiveâ CpG DNA methylation score to predict metastaticâ lethal outcomes in men treated with radical prostatectomy for localized prostate cancer." The Prostate 78(14): 1084-1091.
dc.identifier.issn0270-4137
dc.identifier.issn1097-0045
dc.identifier.urihttps://hdl.handle.net/2027.42/145526
dc.publisherWiley Periodicals, Inc.
dc.subject.otherprognostic
dc.subject.otherprostate cancer
dc.subject.otherbiomarker validation
dc.subject.otherDNA methylation score
dc.subject.othermetastaticâ lethal
dc.titleA fiveâ CpG DNA methylation score to predict metastaticâ lethal outcomes in men treated with radical prostatectomy for localized prostate cancer
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelInternal Medicine and Specialties
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/145526/1/pros23667.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/145526/2/pros23667_am.pdf
dc.identifier.doi10.1002/pros.23667
dc.identifier.sourceThe Prostate
dc.identifier.citedreferenceGray PJ, Lin CC, Cooperberg MR, Jemal A, JA E. Temporal trends and the impact of race, insurance, and socioeconomic status in the management of localized prostate cancer. Eur Urol. 2017; 71: 729 â 737.
dc.identifier.citedreferencePatrikidou A, Loriot Y, Eymard Jâ C, et al. Who dies from prostate cancer ? Prostate Cancer Prostatic Dis. 2014; 17: 348 â 352.
dc.identifier.citedreferenceBhasin JS, Lee BH, Matkin L, et al. Methylomeâ wide sequencing detects DNA hypermethylation distinguishing indolent from aggressive prostate cancer. Cell Reports. 2015; 13: 2135 â 2146.
dc.identifier.citedreferenceErho N, Crisan A, Vergara IA, et al. Discovery and validation of a prostate cancer genomic classifier that predicts early metastasis following radical prostatectomy. PLoS ONE. 2013; 8: e66855.
dc.identifier.citedreferenceHansen K. IlluminaHumanMethylation450kanno.ilmn12.hg19: Annotation for Illumina’s 450k methylation arrays. R package version 0.2.1.
dc.identifier.citedreferenceFreedland SJ, Humphreys EB, Mangold LA, et al. Risk of prostate cancerâ specific mortality following biochemical recurrence after radical prostatectomy. JAMA. 2005; 294: 433 â 439.
dc.identifier.citedreferenceEggener SE, Scardino PT, Walsh PC, et al. Predicting 15â year prostate cancer specific mortality after radical prostatectomy. J Urol. 2011; 185: 869 â 875.
dc.identifier.citedreferenceBoorjian SA, Eastham JA, Graefen M, et al. A critical analysis of the longâ term impact of radical prostatectomy on cancer control and function outcomes. Eur Urol. 2012; 61: 664 â 675.
dc.identifier.citedreferenceDeSantis CE, Lin CC, Mariotto AB, et al. Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin. 2014; 64: 252 â 271.
dc.identifier.citedreferenceHowlader N NA, Krapcho M, Garshell J, et al. SEER Cancer Statistics Review, 1975â 2013. National Cancer Institute, Bethesda, MD Available from: http://seercancergov/csr/1975 2013.
dc.identifier.citedreferenceMundbjerg K, Chopra S, Alemozaffar M, et al. Identifying aggressive prostate cancer foci using a DNA methylation classifier. Genome Biol. 2017; 18: 3.
dc.identifier.citedreferenceMaksimovic J, Gordon L, Oshlack A. SWAN: Subsetâ quantile within array normalization for Illumina infinium HumanMethylation450 BeadChips. Genome Biol. 2012; 13: R44.
dc.identifier.citedreferenceMoskalev EA, Zavgorodnij MG, Majorova SP, et al. Correction of PCRâ bias in quantitative DNA methylation studies by means of cubic polynomical regression. Nucleic Acids Res. 2011; 39: e77.
dc.identifier.citedreferenceBibikova M, Barnes B, Tsan C, et al. High density DNA methylation array with single CpG site resolution. Genomics. 2011; 98: 288 â 295.
dc.identifier.citedreferenceAgalliu I, Salinas CA, Hansten PD, Ostrander EA, Stanford JL. Statin use and risk of prostate cancer: results from a populationâ based epidemiologic study. Am J Epidemiol. 2008; 168: 250 â 260.
dc.identifier.citedreferenceStanford JL, Wicklund KG, McKnight B, Daling JR, Brawer MK. Vasectomy and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev. 1999; 8: 881 â 886.
dc.identifier.citedreferencePaziewska A, Dabrowska M, Goryca K, et al. DNA methylation status is more reliable than gene expression at detecting cancer in prostate biopsy. Br J Cancer. 2014; 111: 781 â 789.
dc.identifier.citedreferenceFriedlander TW, Roy R, Tomlins SA, et al. Common structural and epigenetic changes in the genome of castrationâ resistant prostate cancer. Cancer Res. 2012; 72: 616 â 625.
dc.identifier.citedreferenceMassie CE, Mills IG, Lynch AG. The importance of DNA methylation in prostate cancer development. J Steroid Biochem Mol Biol. 2017; 166: 1 â 15.
dc.identifier.citedreferenceRubicz R, Zhao S, Wright JL, et al. Gene expression panel predicts metastaticâ lethal prostate cancer outcomes in men diagnosed with clinically localized prostate cancer. Mol Oncol. 2017; 11: 140 â 150.
dc.identifier.citedreferenceZhao S, Geybels MS, Leonardson A, et al. Epigenomeâ wide tumor DNA methylation profiling identifies novel prognostic biomarkers of metastaticâ lethal progression in men diagnosed with clinically localized prostate cancer. Clin Cancer Res. 2017; 23: 311 â 319.
dc.identifier.citedreferenceHendriks RJ, van Oort IM, Schalken JA. Bloodâ based and urinary prostate cancer biomarkers: a review and comparison of novel biomarkers for detection and treatment decisions. Prostate Cancer Prostatic Dis. 2017; 20: 12 â 19.
dc.identifier.citedreferenceSpratt DE, Yousefi K, Deheshi S, et al. Individual patientâ level metaâ analysis of the performance of the Decipher genomic classifier in highâ risk men after prostatectomy to predict development of metastatic disease. J Clin Oncol. 2017; 35: 1991 â 1998.
dc.identifier.citedreferenceMoschini M, Spahn M, Mattei A, Cheville J, Karnes RJ. Incorporation of tissueâ based genomic biomarkers into localized prostate cancer clinics. BMC Medicine. 2016; 14: 67.
dc.identifier.citedreferenceBostrom PJ, Bjartell AS, Catto JWF, et al. Genomic predictors of outcome in prostate cancer. Eur Urol. 2015; 68: 1033 â 1044.
dc.identifier.citedreferenceRoss AE, D’Amico AV, Freedland SJ. Which, when and why? Rational use of tissueâ based molecular testing in localized prostate cancer. Prostate Cancer Prostatic Dis. 2016; 19: 1 â 6.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
pros23667.pdf
Size:
442.3KB
Format:
PDF
View/Open
Name:
pros23667_am.pdf
Size:
804.0KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.